The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Detecting hereditary nonpolyposis colorectal cancer syndrome (HNPCC) in patients with colorectal cancer (CRC): Optimal strategies at lower costs.
Daniel Erik Abbott
No relevant relationships to disclose
Scott B. Cantor
No relevant relationships to disclose
Miguel A. Rodriguez-Bigas
No relevant relationships to disclose
George J. Chang
No relevant relationships to disclose
Patrick M Lynch
No relevant relationships to disclose
Barry W. Feig
No relevant relationships to disclose
John Michael Skibber
No relevant relationships to disclose
Y. Nancy You
No relevant relationships to disclose